← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vectorlogics, Inc.
Birmingham, AL
$2,109,296
Total funding
11
Grants
Funding over time
peak $512.5K · FY2006–09$1M$750K$500K$250K$0
'06
'07
'08
'09
Funding mix
By agency
NIH$2,109,296 · 11
By mechanism
R43$1,044,294 · 8
R42$865,002 · 1
R41$200,000 · 2
Investigators at Vectorlogics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Cancer dual-targeting of an infectivity-enhance CRAd$412,501
R42 · FY2008 · CA
Cancer dual-targeting of an infectivity-enhance CRAd$412,501
R42 · FY2009 · CA
ADVANCED GENERATION VECTORS FOR CANCER GENE THERAPY$344,294
R43 · FY2000 · CA
Dual-Modality Imaging of Virotherapy$100,000
R43 · FY2006 · CA
Ad Vector Targeted and Shielded by Humanized Antibodies$100,000
R43 · FY2006 · AI
Ad Vector Targeting Utilizing Capsid-Incorporated Single Domain Antibodies$100,000
R43 · FY2006 · AI
A Shielded Conditionally Replicative Adenoviral Vector$100,000
R43 · FY2007 · CA
Tumor-Specific Replicative Adenoviruses$100,000
R43 · FY2002 · CA
Capsid-Incorporated Antigen for Novel Adenovirus Vaccine$100,000
R43 · FY2008 · CA
Cancer dual-targeting of an infectivity-enchanced CRAd$100,000
R41 · FY2006 · CA
Development of Shielded Adenovirus Vector as a Vaccine Strategy For Anthrax$100,000
R43 · FY2007 · AI
Derivation of Dendritic Cell-Specific Adenovirus Vectors$100,000
R41 · FY2001 · CA
Cancer dual-targeting of an infectivity-enhance CRAd$40,000
R42 · FY2009 · CA